Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery

Not Applicable

Completed

Conditions: Hemifacial Spasm
Microvascular Decompression
Lateral Spread Response Monitoring

Interventions: Other: TOF count-guided partial NMB
Other: T1/Tc guided partial NMB
Other: No NMB

First Posted Date: 2012-05-15

Last Posted Date: 2013-12-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 150

Registration Number: NCT01598961

Locations: 🇰🇷
Samsung Medical Center, Seoul, Gangnam-Gu, Korea, Republic of

Safety of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration : A Prospective Study

Conditions: Ultrasound
Complication

First Posted Date: 2012-05-14

Last Posted Date: 2013-01-03

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 300

Registration Number: NCT01597869

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

The Efficacy of Robot Assisted Group Cognitive Training in Elderly Adults Without Cognitive Impairment

Not Applicable

Completed

Conditions: Age-Related Cognitive Decline

Interventions: Behavioral: Robot assisted cognitive training
Behavioral: Conventional cognitive training group

First Posted Date: 2012-05-10

Last Posted Date: 2012-05-10

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 85

Registration Number: NCT01596205

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Topographic Changes of Retinal Layers After Resolution of Acute Retinal Detachment

Completed

Conditions: Rhegmatogenous Retinal Detachment

First Posted Date: 2012-04-30

Last Posted Date: 2012-04-30

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 21

Registration Number: NCT01587794

Radiomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers

Conditions: Lung Cancer

First Posted Date: 2012-04-26

Last Posted Date: 2022-05-05

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 500

Registration Number: NCT01585545

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma

Phase 2

Terminated

Conditions: Mantle Cell Lymphoma

Interventions: Drug: Fludarabine, Mitoxantrone, Dexamethasone, Vorinostat

First Posted Date: 2012-04-16

Last Posted Date: 2016-04-15

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 20

Registration Number: NCT01578343

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Effect of Shoulder Traction on Size and Relative Position of Internal Jugular Vein to Carotid Artery

Not Applicable

Conditions: Internal Jugular Vein Cannulation
Common Carotid Artery
Infants

Interventions: Other: caudo-ipsilateral traction of shoulder
Other: The ultrasonographic measurements without shoulder traction

First Posted Date: 2012-04-11

Last Posted Date: 2012-04-13

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 25

Registration Number: NCT01575184

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Comparison of Dexmedetomidine and Remifentanil Infusion During CABG

Not Applicable

Completed

Conditions: Coronary Artery Bypass Graft
Hypokalemia
Cardiac Arrhythmia
Dexmedetomidine
Remifentanil

Interventions: Drug: Dexmedetomidine infusion
Drug: Remifentanil infusion

First Posted Date: 2012-04-06

Last Posted Date: 2013-12-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 77

Registration Number: NCT01572454

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura

Completed

Conditions: Idiopathic Thrombocytopenic Purpura

First Posted Date: 2012-04-05

Last Posted Date: 2013-12-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 20

Registration Number: NCT01571349

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting

Phase 3

Completed

Conditions: Laparoscopic Gynecologic, Abdominal, Other Surgery
General Anesthesia

Interventions: Drug: placebo control group
Drug: Palonosetron

First Posted Date: 2012-04-02

Last Posted Date: 2013-12-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 384

Registration Number: NCT01568268

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷
Bungdang Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷
Kangpook Samsung Hospital, Seoul, Korea, Republic of

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy